Biodyne Future Growth
Future criteria checks 5/6
Biodyne is forecast to grow earnings and revenue by 60.9% and 50.6% per annum respectively. EPS is expected to grow by 107.4% per annum. Return on equity is forecast to be 12.8% in 3 years.
Key information
60.9%
Earnings growth rate
107.4%
EPS growth rate
Medical Equipment earnings growth | 34.3% |
Revenue growth rate | 50.6% |
Future return on equity | 12.8% |
Analyst coverage | Low |
Last updated | 09 Jun 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 27,300 | 12,300 | 9,000 | 13,000 | 1 |
12/31/2025 | 11,500 | 4,100 | 5,000 | 5,000 | 1 |
12/31/2024 | 4,100 | -1,300 | N/A | N/A | 1 |
3/31/2024 | 4,076 | -1,332 | -179 | 522 | N/A |
12/31/2023 | 4,089 | -992 | -265 | 405 | N/A |
9/30/2023 | 11,787 | 4,869 | 1,052 | 2,124 | N/A |
6/30/2023 | 12,064 | 5,477 | 808 | 2,045 | N/A |
3/31/2023 | 11,926 | 5,832 | 212 | 1,776 | N/A |
12/31/2022 | 12,210 | 5,611 | 1,023 | 2,586 | N/A |
9/30/2022 | 5,204 | -200 | -633 | 747 | N/A |
6/30/2022 | 4,567 | -995 | -664 | 298 | N/A |
3/31/2022 | 4,506 | -1,160 | -206 | 563 | N/A |
12/31/2021 | 3,763 | -10,857 | -1,371 | -505 | N/A |
9/30/2021 | 3,301 | -12,771 | -264 | 577 | N/A |
6/30/2021 | 3,375 | -13,439 | -189 | 473 | N/A |
3/31/2021 | 3,380 | -13,772 | -736 | -13 | N/A |
12/31/2020 | 3,671 | -4,454 | -807 | 116 | N/A |
9/30/2020 | 4,273 | -4,302 | 3,670 | -1,260 | N/A |
12/31/2019 | 4,089 | -2,026 | 943 | 4,203 | N/A |
12/31/2018 | 3,771 | -1,380 | -252 | 530 | N/A |
12/31/2017 | 4,697 | 513 | N/A | 296 | N/A |
12/31/2015 | 3,609 | -157 | N/A | -656 | N/A |
12/31/2014 | 3,024 | -97 | N/A | 139 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A314930 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: A314930 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A314930 is expected to become profitable in the next 3 years.
Revenue vs Market: A314930's revenue (50.6% per year) is forecast to grow faster than the KR market (10.8% per year).
High Growth Revenue: A314930's revenue (50.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A314930's Return on Equity is forecast to be low in 3 years time (12.8%).